Top Markets
Coin of the day
PJSC Pharmsynthez PJSC Pharmsynthez

PJSC Pharmsynthez

LIFE
Rang in aandelen #34085
PJSC Pharmsynthez, a pharmaceutical enterprise, focuses on the investigation,... PJSC Pharmsynthez, a pharmaceutical enterprise, focuses on the investigation, production, and supply of both proprietary (officinal) and generic active pharmaceutical ingredients across Russia and the Commonwealth of Independent States (CIS). Its portfolio of branded medicines includes Neovir, Segidrin, Fenasid, and Penkrofton, which are employed in critical therapeutic areas such as oncology, gynecology, the management of immune deficiencies, and tuberculosis. Public Joint-Stock Company Pharmsynthez has also established a collaboration with HiFiBiO Therapeutics Inks for the clinical advancement and market introduction of their SARS-CoV-2 neutralizing antibody within Russia. The company, which began operations in 1996, is headquartered in St. Petersburg, Russia.
Aandeelprijs
$0.02082992
Laatst gesynchroniseerd: 2026-08-14
Marktkapitalisatie
$6.27M
Verandering (1 dag)
-3.31%
Verandering (1 jaar)
-51.62%
Land
RU
Handel PJSC Pharmsynthez (LIFE)

Categorie

Koersgeschiedenis voor PJSC Pharmsynthez (LIFE)
Hoogste slotkoers: $0.02 op 2026-08-01

Laagste slotkoers: $0.76 op 2010-11-01
Koersgeschiedenis van PJSC Pharmsynthez van 2010 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -9.44%
2025 30.97%
2024 -44.82%
2023 -11.95%
2022 -18.74%
2021 -19.66%
2020 45.23%
2019 -22.41%
2018 -56.43%
2017 -26.82%
2016 72.01%
2015 -33.83%
2014 -51.22%
2013 7.71%
2012 -30.67%
2011 -14.49%
2010 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE